Jeil Pharm Cash Flow Reinvestment Rate
Jeil Pharm cash flow reinvestment rate. Jeil Pharm (002620) has a Cash Flow Reinvestment Rate of 8.93x as of March 2026, reinvesting ₩3.99 Billion (capex ₩1.72 Billion plus investments ₩-2.27 Billion) from operating cash flow of ₩447.08 Million. Explore Jeil Pharm (002620) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Jeil Pharm (2011–2025)
Cash flow reinvestment rate of Jeil Pharm from 2011 to 2025. Historical reinvestment intensity for Jeil Pharm across 8 annual periods. Explore reinvestment intensity of Jeil Pharm to see what proportion of operating cash flow is directed to capital expenditures.
Jeil Pharm Cash Flow Reinvestment Rate by Year (2011–2025)
Jeil Pharm cash flow reinvestment rate by year from 2011 to 2025. Year-by-year capital reinvestment analysis for Jeil Pharm. For the full cash flow conversion analysis, see cash flow conversion of Jeil Pharm.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 41.01x | ₩16.00 Billion | ₩390.26 Million | ₩9.33 Billion | ▲ +1111.8% |
| 2024 | 3.38x | ₩15.37 Billion | ₩4.54 Billion | ₩6.86 Billion | ▲ +32.6% |
| 2021 | 2.55x | ₩34.19 Billion | ₩13.40 Billion | ₩23.69 Billion | ▲ +44.8% |
| 2019 | 1.76x | ₩44.43 Billion | ₩25.22 Billion | ₩37.69 Billion | ▲ +107.5% |
| 2017 | 0.85x | ₩5.03 Billion | ₩5.92 Billion | ₩2.94 Billion | ▼ -84.0% |
| 2016 | 5.30x | ₩60.20 Billion | ₩11.36 Billion | ₩30.33 Billion | ▲ +87.4% |
| 2015 | 2.83x | ₩7.76 Billion | ₩2.74 Billion | ₩6.74 Billion | ▲ +159.0% |
| 2011 | 1.09x | ₩25.82 Billion | ₩23.63 Billion | ₩22.40 Billion | — |